Biotron (ASX:BIT) #ASX:BIT new share issue oversubscribed bit.ly/2l2S9Ti - thank you to shareholders for participating. Looking forward to data from our Phase 2 #HIV clinical trial and to progressing our promising #HBV #hepatitisB program

#ASX:BIT pleased to announce positive results in its Phase 2 Clinical trial of #BIT225 for #HIV bit.ly/2N7liIL . One step closer to #HIVeradication #HIVcure Biotron (ASX:BIT)

#AX:BIT Biotron (ASX:BIT) approach to tackling serious viruses featured in BioWorld bioworld.com/content/austra… #HIV #virus

What should #investors look for in a promising health stock? Here's how to not miss the next Biotron (ASX:BIT): j.mp/2Pn2hnu $BIT #ASX

Read Biotron (ASX:BIT) latest shareholder newsletter highlighting positive #HIV trial outcome #asx:BIT bit.ly/2QwQ2VA

Biotron (#ASX: $BIT) rides wave of Phase 2 clinical trial success for HIV drug smallcaps.com.au/biotron-phase-… Biotron (ASX:BIT) #biotech

Thinking of those living with HIV and all those no longer with us #WorldAIDSDay We’ve come a long way but not there yet #hivcure

Honoring Stephen Locarnini’s contribution to the field of #Hepatitis B with the Locarnini Fellowship in Virology. #HBV #HBVmeeting19 #HBVmeeting2019

[VIDEO] Executive Series: Biotron (ASX:BIT) (BIT) CEO and MD Dr Michelle Miller speaks about the company’s area of specialisation in anti-viral drug treatments including for HIV, Hepatitis B & Corona virus and its recent success in trials commsec.com.au/market-news/ex… #ausbiz

#BiotronLimited presented latest data #CROI2020 showing that #BIT225 promotes innate immune restoration - one step closer to #HIVCure bit.ly/39HamO4 #HIV #ASX #smallcaps

BIotron’s BIT225 clinical phase antiviral drug prevents severe disease in COVID model. BIT225 is an oral drug which has extensive experience in the clinic through 9 completed clinical trials. bit.ly/3DSEJjp bit.ly.

Biotron Limited Biotron (ASX:BIT) ASX:BIT #ASX presented a webinar today to investors following release of exciting data on #BIT225 against #SARSCoV2 in a #COVID19 model of disease. Watch it now youtu.be/NK1i22J4F8Y

Biotron's BIT225 effective against COVID-19 in animal study biotechdispatch.com.au/news/biotrons-…

.Biotron (ASX:BIT) ‘BIT225 Kills #Sars_Cov_2 In Mice - Game-Changer’ - subscribe to Biotech Daily biotechdaily.com.au

In this ‘On the Couch’ special, Henry Jennings sits down with Michelle Miller (Biotron (ASX:BIT)), Gary Phillips (Pharmaxis) and Jeremy Curnock Cook (BioScience Managers) to discuss what makes a successful #biotech, and how to invest in #medicalscience. bit.ly/3KeUOWy

Great to see some of our clients presenting the biotech story at the #AusMicrocap Investment Conference yesterday Biotron (ASX:BIT) Dimerix Pharmaxis Thank you for inviting us Australian Microcap!

Biotron (ASX:BIT) Hepatitis B virus #HBV program showing early promise in a hot space #hepatitisB #ASX

Great to see shareholders at yesterday's #BIT Biotron (ASX:BIT) AGM. Chairman's Address and the CEO Presentation are online at bit.ly/2AgVU16 #ASX #HIV #cure #HBV

Thanks to outgoing Biotron (ASX:BIT) Director, Prof Denis Wade, for his dedication and contributions to the Company bit.ly/2hGi7KH #ASX #BIT